XML 45 R4.htm IDEA: XBRL DOCUMENT v3.19.3
CONSOLIDATED CONDENSED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS (Unaudited) - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2019
Sep. 30, 2018
Sep. 30, 2019
Sep. 30, 2018
Income Statement [Abstract]        
Revenues $ 57,389 $ 44,635 $ 149,896 $ 132,681
Cost of goods sold 53,407 41,967 142,992 125,379
Gross profit 3,982 2,668 6,904 7,302
Research and development expenses 37 74 160 191
Selling, general and administrative expenses 4,529 3,893 12,715 11,289
Operating loss (584) (1,299) (5,971) (4,178)
Interest expense        
Interest rate expense 5,396 4,692 15,572 13,395
Debt related fees and amortization expense 946 719 3,565 6,395
Accretion of Series A preferred units 589 0 1,509 0
Loss contingency on litigation 0 0 6,200 0
Other (income) expense (289) (61) (1,001) 2
Loss before income taxes (7,226) (6,649) (31,816) (23,970)
Income tax expense 0 0 7 6
Net loss (7,226) (6,649) (31,823) (23,976)
Less: Net loss attributable to non-controlling interest (900) (792) (2,832) (2,386)
Net loss attributable to Aemetis, Inc. (6,326) (5,857) (28,991) (21,590)
Other comprehensive income (loss)        
Foreign currency translation gain (loss) (254) (423) (139) (967)
Comprehensive loss $ (7,480) $ (7,072) $ (31,962) $ (24,943)
Net loss per common share attributable to Aemetis, Inc.        
Basic $ (0.31) $ (0.29) $ (1.42) $ (1.07)
Diluted $ (0.31) $ (0.29) $ (1.42) $ (1.07)
Weighted average shares outstanding        
Basic 20,554 20,252 20,433 20,220
Diluted 20,554 20,252 20,433 20,220